nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—TNF—osteoporosis	0.398	1	CbGaD
Epinephrine—SLC22A1—Estropipate—osteoporosis	0.0935	0.239	CbGbCtD
Epinephrine—SLC22A2—Estradiol—osteoporosis	0.0447	0.114	CbGbCtD
Epinephrine—SLC22A1—Estradiol—osteoporosis	0.0388	0.0994	CbGbCtD
Epinephrine—CYP1A2—Estropipate—osteoporosis	0.0328	0.0839	CbGbCtD
Epinephrine—CYP2C9—Estropipate—osteoporosis	0.0295	0.0756	CbGbCtD
Epinephrine—CYP3A4—Estropipate—osteoporosis	0.0172	0.044	CbGbCtD
Epinephrine—CYP3A4—Calcitriol—osteoporosis	0.0172	0.044	CbGbCtD
Epinephrine—CYP1A2—Conjugated Estrogens—osteoporosis	0.0155	0.0397	CbGbCtD
Epinephrine—CYP2C9—Cholecalciferol—osteoporosis	0.0152	0.0389	CbGbCtD
Epinephrine—CYP3A4—Ergocalciferol—osteoporosis	0.0137	0.0351	CbGbCtD
Epinephrine—CYP1A2—Estradiol—osteoporosis	0.0136	0.0348	CbGbCtD
Epinephrine—CYP2C9—Estradiol—osteoporosis	0.0123	0.0314	CbGbCtD
Epinephrine—CYP3A4—Raloxifene—osteoporosis	0.0115	0.0293	CbGbCtD
Epinephrine—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0111	0.0283	CbGbCtD
Epinephrine—CYP3A4—Cholecalciferol—osteoporosis	0.00884	0.0226	CbGbCtD
Epinephrine—CYP3A4—Conjugated Estrogens—osteoporosis	0.00812	0.0208	CbGbCtD
Epinephrine—CYP3A4—Estradiol—osteoporosis	0.00713	0.0183	CbGbCtD
Epinephrine—Necrosis—Calcium Acetate—osteoporosis	0.00259	0.0226	CcSEcCtD
Epinephrine—Tingling sensation—Calcium Acetate—osteoporosis	0.00253	0.022	CcSEcCtD
Epinephrine—Rales—Pamidronate—osteoporosis	0.00212	0.0184	CcSEcCtD
Epinephrine—Local reaction—Ibandronate—osteoporosis	0.002	0.0174	CcSEcCtD
Epinephrine—Nephropathy—Pamidronate—osteoporosis	0.00182	0.0159	CcSEcCtD
Epinephrine—Local reaction—Ethinyl Estradiol—osteoporosis	0.00169	0.0147	CcSEcCtD
Epinephrine—Local reaction—Pamidronate—osteoporosis	0.00157	0.0137	CcSEcCtD
Epinephrine—Local reaction—Zoledronate—osteoporosis	0.00143	0.0125	CcSEcCtD
Epinephrine—Myocardial ischaemia—Ibandronate—osteoporosis	0.00138	0.012	CcSEcCtD
Epinephrine—Drug interaction—Alendronate—osteoporosis	0.00123	0.0107	CcSEcCtD
Epinephrine—Blood pressure increased—Estropipate—osteoporosis	0.00116	0.0101	CcSEcCtD
Epinephrine—Blood pressure increased—Raloxifene—osteoporosis	0.00112	0.00975	CcSEcCtD
Epinephrine—Contusion—Risedronate—osteoporosis	0.00105	0.00912	CcSEcCtD
Epinephrine—Pulmonary oedema—Ibandronate—osteoporosis	0.000987	0.00859	CcSEcCtD
Epinephrine—Necrosis—Conjugated Estrogens—osteoporosis	0.000974	0.00847	CcSEcCtD
Epinephrine—Tingling sensation—Conjugated Estrogens—osteoporosis	0.000951	0.00827	CcSEcCtD
Epinephrine—Blood pressure increased—Ethinyl Estradiol—osteoporosis	0.000937	0.00816	CcSEcCtD
Epinephrine—Arrhythmia—Calcium Acetate—osteoporosis	0.000914	0.00795	CcSEcCtD
Epinephrine—Extravasation—Conjugated Estrogens—osteoporosis	0.000876	0.00762	CcSEcCtD
Epinephrine—Cerebrovascular accident—Estropipate—osteoporosis	0.000857	0.00746	CcSEcCtD
Epinephrine—Renal impairment—Ibandronate—osteoporosis	0.000846	0.00736	CcSEcCtD
Epinephrine—Cerebrovascular accident—Raloxifene—osteoporosis	0.00083	0.00722	CcSEcCtD
Epinephrine—Pulmonary oedema—Pamidronate—osteoporosis	0.000773	0.00673	CcSEcCtD
Epinephrine—Psychotic disorder—Calcitriol—osteoporosis	0.00077	0.0067	CcSEcCtD
Epinephrine—Blood pressure increased—Conjugated Estrogens—osteoporosis	0.000764	0.00665	CcSEcCtD
Epinephrine—Myocardial ischaemia—Estradiol—osteoporosis	0.000761	0.00662	CcSEcCtD
Epinephrine—Contusion—Estradiol—osteoporosis	0.000701	0.0061	CcSEcCtD
Epinephrine—Cerebrovascular accident—Ethinyl Estradiol—osteoporosis	0.000694	0.00604	CcSEcCtD
Epinephrine—Lightheadedness—Conjugated Estrogens—osteoporosis	0.000684	0.00595	CcSEcCtD
Epinephrine—Hypertension—Ergocalciferol—osteoporosis	0.000679	0.00591	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Estradiol—osteoporosis	0.000677	0.00589	CcSEcCtD
Epinephrine—Hallucination—Etidronic acid—osteoporosis	0.000668	0.00581	CcSEcCtD
Epinephrine—Drug interaction—Estradiol—osteoporosis	0.000659	0.00574	CcSEcCtD
Epinephrine—Hyperglycaemia—Estropipate—osteoporosis	0.000655	0.0057	CcSEcCtD
Epinephrine—Paraesthesia—Calcium Acetate—osteoporosis	0.000652	0.00568	CcSEcCtD
Epinephrine—Acute coronary syndrome—Estropipate—osteoporosis	0.000638	0.00555	CcSEcCtD
Epinephrine—Myocardial infarction—Estropipate—osteoporosis	0.000634	0.00552	CcSEcCtD
Epinephrine—Disorientation—Conjugated Estrogens—osteoporosis	0.00062	0.0054	CcSEcCtD
Epinephrine—Psychotic disorder—Pamidronate—osteoporosis	0.000616	0.00536	CcSEcCtD
Epinephrine—Blood pressure increased—Estradiol—osteoporosis	0.000612	0.00532	CcSEcCtD
Epinephrine—Renal failure—Ibandronate—osteoporosis	0.00061	0.00531	CcSEcCtD
Epinephrine—Drowsiness—Calcitriol—osteoporosis	0.000607	0.00528	CcSEcCtD
Epinephrine—Renal impairment—Zoledronate—osteoporosis	0.000605	0.00527	CcSEcCtD
Epinephrine—Sweating—Raloxifene—osteoporosis	0.000601	0.00523	CcSEcCtD
Epinephrine—Sweating—Ibandronate—osteoporosis	0.000595	0.00518	CcSEcCtD
Epinephrine—Erythema—Etidronic acid—osteoporosis	0.000584	0.00509	CcSEcCtD
Epinephrine—Skin exfoliation—Estradiol—osteoporosis	0.000584	0.00508	CcSEcCtD
Epinephrine—Renal impairment—Conjugated Estrogens—osteoporosis	0.000583	0.00507	CcSEcCtD
Epinephrine—Haemoglobin—Alendronate—osteoporosis	0.000575	0.005	CcSEcCtD
Epinephrine—Hypokalaemia—Pamidronate—osteoporosis	0.000574	0.00499	CcSEcCtD
Epinephrine—Haemorrhage—Alendronate—osteoporosis	0.000572	0.00498	CcSEcCtD
Epinephrine—Cerebrovascular accident—Conjugated Estrogens—osteoporosis	0.000566	0.00493	CcSEcCtD
Epinephrine—Haemoglobin—Ibandronate—osteoporosis	0.00056	0.00487	CcSEcCtD
Epinephrine—Hypoaesthesia—Raloxifene—osteoporosis	0.00056	0.00487	CcSEcCtD
Epinephrine—Haemorrhage—Ibandronate—osteoporosis	0.000557	0.00485	CcSEcCtD
Epinephrine—Haemoglobin—Calcitriol—osteoporosis	0.000548	0.00477	CcSEcCtD
Epinephrine—Haemorrhage—Calcitriol—osteoporosis	0.000545	0.00474	CcSEcCtD
Epinephrine—Sweating increased—Pamidronate—osteoporosis	0.000531	0.00462	CcSEcCtD
Epinephrine—Hypokalaemia—Zoledronate—osteoporosis	0.000524	0.00456	CcSEcCtD
Epinephrine—Flushing—Raloxifene—osteoporosis	0.000522	0.00454	CcSEcCtD
Epinephrine—Acute coronary syndrome—Ethinyl Estradiol—osteoporosis	0.000517	0.0045	CcSEcCtD
Epinephrine—Myocardial infarction—Ethinyl Estradiol—osteoporosis	0.000514	0.00447	CcSEcCtD
Epinephrine—Mental disorder—Estropipate—osteoporosis	0.000509	0.00443	CcSEcCtD
Epinephrine—Erythema—Estropipate—osteoporosis	0.000506	0.0044	CcSEcCtD
Epinephrine—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.000505	0.00439	CcSEcCtD
Epinephrine—Erythema—Alendronate—osteoporosis	0.000498	0.00433	CcSEcCtD
Epinephrine—Tension—Estropipate—osteoporosis	0.000496	0.00432	CcSEcCtD
Epinephrine—Nervousness—Estropipate—osteoporosis	0.000491	0.00427	CcSEcCtD
Epinephrine—Mental disorder—Ibandronate—osteoporosis	0.000488	0.00425	CcSEcCtD
Epinephrine—Arrhythmia—Calcitriol—osteoporosis	0.000487	0.00424	CcSEcCtD
Epinephrine—Sweating increased—Zoledronate—osteoporosis	0.000485	0.00422	CcSEcCtD
Epinephrine—Erythema—Ibandronate—osteoporosis	0.000485	0.00422	CcSEcCtD
Epinephrine—Dizziness—Calcium Acetate—osteoporosis	0.00048	0.00418	CcSEcCtD
Epinephrine—Renal failure—Pamidronate—osteoporosis	0.000478	0.00416	CcSEcCtD
Epinephrine—Erythema—Calcitriol—osteoporosis	0.000475	0.00413	CcSEcCtD
Epinephrine—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.000473	0.00412	CcSEcCtD
Epinephrine—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.000471	0.0041	CcSEcCtD
Epinephrine—Hypoaesthesia—Ethinyl Estradiol—osteoporosis	0.000468	0.00408	CcSEcCtD
Epinephrine—Sweating increased—Conjugated Estrogens—osteoporosis	0.000467	0.00406	CcSEcCtD
Epinephrine—Vomiting—Calcium Acetate—osteoporosis	0.000462	0.00402	CcSEcCtD
Epinephrine—Haemoglobin—Risedronate—osteoporosis	0.000461	0.00401	CcSEcCtD
Epinephrine—Haemorrhage—Risedronate—osteoporosis	0.000459	0.00399	CcSEcCtD
Epinephrine—Cerebrovascular accident—Estradiol—osteoporosis	0.000453	0.00394	CcSEcCtD
Epinephrine—Palpitations—Estropipate—osteoporosis	0.000447	0.00389	CcSEcCtD
Epinephrine—Haemoglobin—Pamidronate—osteoporosis	0.000439	0.00382	CcSEcCtD
Epinephrine—Renal failure—Zoledronate—osteoporosis	0.000436	0.0038	CcSEcCtD
Epinephrine—Haemorrhage—Pamidronate—osteoporosis	0.000436	0.0038	CcSEcCtD
Epinephrine—Agitation—Calcitriol—osteoporosis	0.000436	0.0038	CcSEcCtD
Epinephrine—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000432	0.00376	CcSEcCtD
Epinephrine—Nausea—Calcium Acetate—osteoporosis	0.000432	0.00376	CcSEcCtD
Epinephrine—Palpitations—Ibandronate—osteoporosis	0.000428	0.00373	CcSEcCtD
Epinephrine—Paraesthesia—Etidronic acid—osteoporosis	0.000428	0.00373	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000427	0.00372	CcSEcCtD
Epinephrine—Chest pain—Alendronate—osteoporosis	0.000424	0.00369	CcSEcCtD
Epinephrine—Acute coronary syndrome—Conjugated Estrogens—osteoporosis	0.000421	0.00367	CcSEcCtD
Epinephrine—Renal failure—Conjugated Estrogens—osteoporosis	0.00042	0.00366	CcSEcCtD
Epinephrine—Myocardial infarction—Conjugated Estrogens—osteoporosis	0.000419	0.00365	CcSEcCtD
Epinephrine—Hypertension—Ibandronate—osteoporosis	0.000419	0.00364	CcSEcCtD
Epinephrine—Chest pain—Raloxifene—osteoporosis	0.000417	0.00363	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000414	0.0036	CcSEcCtD
Epinephrine—Chest pain—Ibandronate—osteoporosis	0.000413	0.00359	CcSEcCtD
Epinephrine—Mental disorder—Ethinyl Estradiol—osteoporosis	0.000412	0.00359	CcSEcCtD
Epinephrine—Arrhythmia—Risedronate—osteoporosis	0.00041	0.00357	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00041	0.00357	CcSEcCtD
Epinephrine—Hypertension—Calcitriol—osteoporosis	0.00041	0.00357	CcSEcCtD
Epinephrine—Flushing—Pamidronate—osteoporosis	0.000405	0.00352	CcSEcCtD
Epinephrine—Nervous system disorder—Estropipate—osteoporosis	0.000405	0.00352	CcSEcCtD
Epinephrine—Chest pain—Calcitriol—osteoporosis	0.000404	0.00352	CcSEcCtD
Epinephrine—Mental disorder—Risedronate—osteoporosis	0.000402	0.0035	CcSEcCtD
Epinephrine—Skin disorder—Estropipate—osteoporosis	0.000401	0.00349	CcSEcCtD
Epinephrine—Hypoaesthesia—Zoledronate—osteoporosis	0.000397	0.00345	CcSEcCtD
Epinephrine—Nervous system disorder—Raloxifene—osteoporosis	0.000392	0.00341	CcSEcCtD
Epinephrine—Skin disorder—Raloxifene—osteoporosis	0.000388	0.00338	CcSEcCtD
Epinephrine—Nervous system disorder—Ibandronate—osteoporosis	0.000388	0.00338	CcSEcCtD
Epinephrine—Hyperhidrosis—Raloxifene—osteoporosis	0.000386	0.00336	CcSEcCtD
Epinephrine—Skin disorder—Ibandronate—osteoporosis	0.000384	0.00334	CcSEcCtD
Epinephrine—Hyperhidrosis—Ibandronate—osteoporosis	0.000383	0.00333	CcSEcCtD
Epinephrine—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000382	0.00332	CcSEcCtD
Epinephrine—Nausea—Ergocalciferol—osteoporosis	0.000381	0.00332	CcSEcCtD
Epinephrine—Erythema—Pamidronate—osteoporosis	0.00038	0.00331	CcSEcCtD
Epinephrine—Skin disorder—Calcitriol—osteoporosis	0.000376	0.00327	CcSEcCtD
Epinephrine—Sweating increased—Estradiol—osteoporosis	0.000374	0.00325	CcSEcCtD
Epinephrine—Insomnia—Estropipate—osteoporosis	0.000373	0.00325	CcSEcCtD
Epinephrine—Tension—Pamidronate—osteoporosis	0.000373	0.00324	CcSEcCtD
Epinephrine—Paraesthesia—Estropipate—osteoporosis	0.000371	0.00322	CcSEcCtD
Epinephrine—Flushing—Zoledronate—osteoporosis	0.00037	0.00322	CcSEcCtD
Epinephrine—Nervousness—Pamidronate—osteoporosis	0.000369	0.00321	CcSEcCtD
Epinephrine—Somnolence—Estropipate—osteoporosis	0.000367	0.00319	CcSEcCtD
Epinephrine—Insomnia—Raloxifene—osteoporosis	0.000361	0.00315	CcSEcCtD
Epinephrine—Insomnia—Ibandronate—osteoporosis	0.000358	0.00311	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Estropipate—osteoporosis	0.000356	0.0031	CcSEcCtD
Epinephrine—Arrhythmia—Zoledronate—osteoporosis	0.000356	0.0031	CcSEcCtD
Epinephrine—Paraesthesia—Ibandronate—osteoporosis	0.000355	0.00309	CcSEcCtD
Epinephrine—Insomnia—Calcitriol—osteoporosis	0.00035	0.00305	CcSEcCtD
Epinephrine—Mental disorder—Zoledronate—osteoporosis	0.000349	0.00304	CcSEcCtD
Epinephrine—Agitation—Pamidronate—osteoporosis	0.000349	0.00304	CcSEcCtD
Epinephrine—Erythema—Zoledronate—osteoporosis	0.000347	0.00302	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000346	0.00302	CcSEcCtD
Epinephrine—Hyperglycaemia—Estradiol—osteoporosis	0.000346	0.00301	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000345	0.003	CcSEcCtD
Epinephrine—Hypertension—Risedronate—osteoporosis	0.000345	0.003	CcSEcCtD
Epinephrine—Somnolence—Calcitriol—osteoporosis	0.000344	0.003	CcSEcCtD
Epinephrine—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000343	0.00298	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000342	0.00297	CcSEcCtD
Epinephrine—Chest pain—Risedronate—osteoporosis	0.00034	0.00296	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000338	0.00294	CcSEcCtD
Epinephrine—Acute coronary syndrome—Estradiol—osteoporosis	0.000337	0.00293	CcSEcCtD
Epinephrine—Mental disorder—Conjugated Estrogens—osteoporosis	0.000336	0.00293	CcSEcCtD
Epinephrine—Myocardial infarction—Estradiol—osteoporosis	0.000335	0.00292	CcSEcCtD
Epinephrine—Erythema—Conjugated Estrogens—osteoporosis	0.000334	0.00291	CcSEcCtD
Epinephrine—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000328	0.00285	CcSEcCtD
Epinephrine—Hypertension—Pamidronate—osteoporosis	0.000328	0.00285	CcSEcCtD
Epinephrine—Tension—Conjugated Estrogens—osteoporosis	0.000328	0.00285	CcSEcCtD
Epinephrine—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000325	0.00283	CcSEcCtD
Epinephrine—Nervousness—Conjugated Estrogens—osteoporosis	0.000324	0.00282	CcSEcCtD
Epinephrine—Nervous system disorder—Risedronate—osteoporosis	0.00032	0.00278	CcSEcCtD
Epinephrine—Agitation—Zoledronate—osteoporosis	0.000319	0.00277	CcSEcCtD
Epinephrine—Skin disorder—Risedronate—osteoporosis	0.000317	0.00276	CcSEcCtD
Epinephrine—Haemoglobin—Estradiol—osteoporosis	0.000309	0.00269	CcSEcCtD
Epinephrine—Haemorrhage—Estradiol—osteoporosis	0.000307	0.00267	CcSEcCtD
Epinephrine—Palpitations—Zoledronate—osteoporosis	0.000307	0.00267	CcSEcCtD
Epinephrine—Hypoaesthesia—Estradiol—osteoporosis	0.000306	0.00266	CcSEcCtD
Epinephrine—Nervous system disorder—Pamidronate—osteoporosis	0.000304	0.00265	CcSEcCtD
Epinephrine—Vomiting—Etidronic acid—osteoporosis	0.000303	0.00264	CcSEcCtD
Epinephrine—Tachycardia—Pamidronate—osteoporosis	0.000303	0.00263	CcSEcCtD
Epinephrine—Hyperhidrosis—Pamidronate—osteoporosis	0.0003	0.00261	CcSEcCtD
Epinephrine—Hypertension—Zoledronate—osteoporosis	0.0003	0.00261	CcSEcCtD
Epinephrine—Chest pain—Zoledronate—osteoporosis	0.000295	0.00257	CcSEcCtD
Epinephrine—Palpitations—Conjugated Estrogens—osteoporosis	0.000295	0.00257	CcSEcCtD
Epinephrine—Insomnia—Risedronate—osteoporosis	0.000295	0.00257	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000293	0.00255	CcSEcCtD
Epinephrine—Paraesthesia—Risedronate—osteoporosis	0.000293	0.00255	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000289	0.00251	CcSEcCtD
Epinephrine—Flushing—Estradiol—osteoporosis	0.000285	0.00248	CcSEcCtD
Epinephrine—Chest pain—Conjugated Estrogens—osteoporosis	0.000284	0.00247	CcSEcCtD
Epinephrine—Nausea—Etidronic acid—osteoporosis	0.000283	0.00247	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000282	0.00246	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Risedronate—osteoporosis	0.000282	0.00245	CcSEcCtD
Epinephrine—Insomnia—Pamidronate—osteoporosis	0.00028	0.00244	CcSEcCtD
Epinephrine—Paraesthesia—Pamidronate—osteoporosis	0.000278	0.00242	CcSEcCtD
Epinephrine—Nervous system disorder—Zoledronate—osteoporosis	0.000278	0.00242	CcSEcCtD
Epinephrine—Tachycardia—Zoledronate—osteoporosis	0.000276	0.0024	CcSEcCtD
Epinephrine—Somnolence—Pamidronate—osteoporosis	0.000276	0.0024	CcSEcCtD
Epinephrine—Skin disorder—Zoledronate—osteoporosis	0.000275	0.00239	CcSEcCtD
Epinephrine—Hyperhidrosis—Zoledronate—osteoporosis	0.000274	0.00238	CcSEcCtD
Epinephrine—Dizziness—Estropipate—osteoporosis	0.000273	0.00237	CcSEcCtD
Epinephrine—Mental disorder—Estradiol—osteoporosis	0.000269	0.00234	CcSEcCtD
Epinephrine—Dizziness—Alendronate—osteoporosis	0.000269	0.00234	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000268	0.00233	CcSEcCtD
Epinephrine—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000267	0.00233	CcSEcCtD
Epinephrine—Erythema—Estradiol—osteoporosis	0.000267	0.00233	CcSEcCtD
Epinephrine—Tachycardia—Conjugated Estrogens—osteoporosis	0.000266	0.00232	CcSEcCtD
Epinephrine—Skin disorder—Conjugated Estrogens—osteoporosis	0.000265	0.0023	CcSEcCtD
Epinephrine—Dizziness—Raloxifene—osteoporosis	0.000264	0.0023	CcSEcCtD
Epinephrine—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000264	0.00229	CcSEcCtD
Epinephrine—Tension—Estradiol—osteoporosis	0.000262	0.00228	CcSEcCtD
Epinephrine—Vomiting—Estropipate—osteoporosis	0.000262	0.00228	CcSEcCtD
Epinephrine—Dizziness—Ibandronate—osteoporosis	0.000262	0.00228	CcSEcCtD
Epinephrine—Nervousness—Estradiol—osteoporosis	0.00026	0.00226	CcSEcCtD
Epinephrine—Vomiting—Alendronate—osteoporosis	0.000258	0.00225	CcSEcCtD
Epinephrine—Insomnia—Zoledronate—osteoporosis	0.000256	0.00223	CcSEcCtD
Epinephrine—Paraesthesia—Zoledronate—osteoporosis	0.000254	0.00221	CcSEcCtD
Epinephrine—Vomiting—Raloxifene—osteoporosis	0.000254	0.00221	CcSEcCtD
Epinephrine—Somnolence—Zoledronate—osteoporosis	0.000252	0.00219	CcSEcCtD
Epinephrine—Vomiting—Ibandronate—osteoporosis	0.000252	0.00219	CcSEcCtD
Epinephrine—Insomnia—Conjugated Estrogens—osteoporosis	0.000247	0.00215	CcSEcCtD
Epinephrine—Vomiting—Calcitriol—osteoporosis	0.000246	0.00214	CcSEcCtD
Epinephrine—Agitation—Estradiol—osteoporosis	0.000246	0.00214	CcSEcCtD
Epinephrine—Nausea—Estropipate—osteoporosis	0.000245	0.00213	CcSEcCtD
Epinephrine—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000245	0.00213	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000244	0.00213	CcSEcCtD
Epinephrine—Somnolence—Conjugated Estrogens—osteoporosis	0.000242	0.00211	CcSEcCtD
Epinephrine—Nausea—Alendronate—osteoporosis	0.000241	0.0021	CcSEcCtD
Epinephrine—Nausea—Raloxifene—osteoporosis	0.000237	0.00207	CcSEcCtD
Epinephrine—Palpitations—Estradiol—osteoporosis	0.000236	0.00206	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000235	0.00205	CcSEcCtD
Epinephrine—Nausea—Ibandronate—osteoporosis	0.000235	0.00205	CcSEcCtD
Epinephrine—Hypertension—Estradiol—osteoporosis	0.000231	0.00201	CcSEcCtD
Epinephrine—Nausea—Calcitriol—osteoporosis	0.00023	0.002	CcSEcCtD
Epinephrine—Chest pain—Estradiol—osteoporosis	0.000228	0.00198	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000226	0.00197	CcSEcCtD
Epinephrine—Dizziness—Ethinyl Estradiol—osteoporosis	0.000221	0.00192	CcSEcCtD
Epinephrine—Dizziness—Risedronate—osteoporosis	0.000216	0.00188	CcSEcCtD
Epinephrine—Nervous system disorder—Estradiol—osteoporosis	0.000214	0.00186	CcSEcCtD
Epinephrine—Tachycardia—Estradiol—osteoporosis	0.000213	0.00185	CcSEcCtD
Epinephrine—Vomiting—Ethinyl Estradiol—osteoporosis	0.000213	0.00185	CcSEcCtD
Epinephrine—Skin disorder—Estradiol—osteoporosis	0.000212	0.00184	CcSEcCtD
Epinephrine—Hyperhidrosis—Estradiol—osteoporosis	0.000211	0.00184	CcSEcCtD
Epinephrine—Vomiting—Risedronate—osteoporosis	0.000207	0.0018	CcSEcCtD
Epinephrine—Dizziness—Pamidronate—osteoporosis	0.000205	0.00178	CcSEcCtD
Epinephrine—Nausea—Ethinyl Estradiol—osteoporosis	0.000199	0.00173	CcSEcCtD
Epinephrine—Insomnia—Estradiol—osteoporosis	0.000197	0.00172	CcSEcCtD
Epinephrine—Vomiting—Pamidronate—osteoporosis	0.000197	0.00172	CcSEcCtD
Epinephrine—Paraesthesia—Estradiol—osteoporosis	0.000196	0.00171	CcSEcCtD
Epinephrine—Somnolence—Estradiol—osteoporosis	0.000194	0.00169	CcSEcCtD
Epinephrine—Nausea—Risedronate—osteoporosis	0.000194	0.00169	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Estradiol—osteoporosis	0.000188	0.00164	CcSEcCtD
Epinephrine—Dizziness—Zoledronate—osteoporosis	0.000187	0.00163	CcSEcCtD
Epinephrine—Nausea—Pamidronate—osteoporosis	0.000184	0.0016	CcSEcCtD
Epinephrine—Dizziness—Conjugated Estrogens—osteoporosis	0.00018	0.00157	CcSEcCtD
Epinephrine—Vomiting—Zoledronate—osteoporosis	0.00018	0.00157	CcSEcCtD
Epinephrine—Vomiting—Conjugated Estrogens—osteoporosis	0.000173	0.00151	CcSEcCtD
Epinephrine—Nausea—Zoledronate—osteoporosis	0.000168	0.00146	CcSEcCtD
Epinephrine—Nausea—Conjugated Estrogens—osteoporosis	0.000162	0.00141	CcSEcCtD
Epinephrine—Dizziness—Estradiol—osteoporosis	0.000144	0.00126	CcSEcCtD
Epinephrine—Vomiting—Estradiol—osteoporosis	0.000139	0.00121	CcSEcCtD
Epinephrine—Nausea—Estradiol—osteoporosis	0.00013	0.00113	CcSEcCtD
Epinephrine—ADRB2—Signaling Pathways—CALCA—osteoporosis	1.31e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PSMA2—osteoporosis	1.31e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PSMA5—osteoporosis	1.31e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—POMC—osteoporosis	1.3e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—ADCY5—osteoporosis	1.3e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—POMC—osteoporosis	1.3e-05	0.000135	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.3e-05	0.000135	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—POMC—osteoporosis	1.29e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PSMA2—osteoporosis	1.29e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PSMA5—osteoporosis	1.29e-05	0.000134	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CYP19A1—osteoporosis	1.29e-05	0.000134	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.29e-05	0.000134	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ATIC—osteoporosis	1.28e-05	0.000133	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PNP—osteoporosis	1.28e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—POMC—osteoporosis	1.28e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6R—osteoporosis	1.27e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—WNT1—osteoporosis	1.26e-05	0.000131	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ACP5—osteoporosis	1.25e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CALCA—osteoporosis	1.24e-05	0.000129	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.24e-05	0.000128	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CYP19A1—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTHLH—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—BMP2—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGA—osteoporosis	1.23e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IRS1—osteoporosis	1.22e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CALCA—osteoporosis	1.22e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KL—osteoporosis	1.21e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MYC—osteoporosis	1.21e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—ADCY5—osteoporosis	1.21e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—TGFB1—osteoporosis	1.21e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—POMC—osteoporosis	1.21e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KL—osteoporosis	1.2e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—FGB—osteoporosis	1.2e-05	0.000125	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—POMC—osteoporosis	1.19e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KL—osteoporosis	1.19e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—POMC—osteoporosis	1.18e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TGFB1—osteoporosis	1.18e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—POMC—osteoporosis	1.18e-05	0.000122	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—POMC—osteoporosis	1.17e-05	0.000122	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—IDH2—osteoporosis	1.17e-05	0.000121	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TPI1—osteoporosis	1.16e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PSMA2—osteoporosis	1.16e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PSMA5—osteoporosis	1.16e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—POMC—osteoporosis	1.16e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6R—osteoporosis	1.16e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6R—osteoporosis	1.15e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6R—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTHLH—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BMP2—osteoporosis	1.14e-05	0.000119	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IGF1—osteoporosis	1.13e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6R—osteoporosis	1.13e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KL—osteoporosis	1.12e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—FGB—osteoporosis	1.12e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KL—osteoporosis	1.11e-05	0.000115	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TGFB1—osteoporosis	1.1e-05	0.000114	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.1e-05	0.000114	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—POMC—osteoporosis	1.1e-05	0.000114	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—P4HB—osteoporosis	1.09e-05	0.000114	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CA2—osteoporosis	1.09e-05	0.000113	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—OXCT1—osteoporosis	1.09e-05	0.000113	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—IL6—osteoporosis	1.08e-05	0.000113	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ADCY5—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CALCA—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL6—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—POMC—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GPX1—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PSMA2—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PSMA5—osteoporosis	1.08e-05	0.000112	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GAPDH—osteoporosis	1.07e-05	0.000112	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ACP5—osteoporosis	1.07e-05	0.000111	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6R—osteoporosis	1.07e-05	0.000111	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MGLL—osteoporosis	1.06e-05	0.00011	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.06e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—POMC—osteoporosis	1.06e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ADCY5—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6R—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GPX1—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CYP19A1—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—RAP1A—osteoporosis	1.05e-05	0.000109	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ADCY5—osteoporosis	1.04e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SPP1—osteoporosis	1.01e-05	0.000105	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ADCY5—osteoporosis	1.01e-05	0.000105	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GPX1—osteoporosis	1.01e-05	0.000104	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CALCA—osteoporosis	1.01e-05	0.000104	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—MTHFR—osteoporosis	9.95e-06	0.000103	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TPI1—osteoporosis	9.95e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL6—osteoporosis	9.87e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KL—osteoporosis	9.82e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—POMC—osteoporosis	9.8e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—MTHFR—osteoporosis	9.68e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—POMC—osteoporosis	9.58e-06	9.95e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ADCY5—osteoporosis	9.51e-06	9.88e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ADCY5—osteoporosis	9.42e-06	9.79e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—P4HB—osteoporosis	9.35e-06	9.71e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6R—osteoporosis	9.35e-06	9.71e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ADCY5—osteoporosis	9.3e-06	9.66e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—MTHFR—osteoporosis	9.28e-06	9.64e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SPP1—osteoporosis	9.2e-06	9.56e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GAPDH—osteoporosis	9.18e-06	9.53e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IRS2—osteoporosis	9.13e-06	9.49e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KL—osteoporosis	9.13e-06	9.48e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.12e-06	9.48e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SPP1—osteoporosis	9.12e-06	9.47e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—IL6—osteoporosis	9.11e-06	9.46e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—IDH2—osteoporosis	9.03e-06	9.38e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SPP1—osteoporosis	9e-06	9.35e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TGFB1—osteoporosis	8.95e-06	9.29e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—RAP1A—osteoporosis	8.94e-06	9.28e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—LEP—osteoporosis	8.94e-06	9.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—POMC—osteoporosis	8.9e-06	9.25e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ADCY5—osteoporosis	8.8e-06	9.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6R—osteoporosis	8.68e-06	9.02e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL6—osteoporosis	8.67e-06	9e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ADCY5—osteoporosis	8.66e-06	9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ADCY5—osteoporosis	8.55e-06	8.88e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ESR1—osteoporosis	8.53e-06	8.86e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GPX1—osteoporosis	8.52e-06	8.85e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SPP1—osteoporosis	8.52e-06	8.85e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.49e-06	8.82e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—osteoporosis	8.49e-06	8.81e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFB1—osteoporosis	8.47e-06	8.79e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO1—osteoporosis	8.46e-06	8.78e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SPP1—osteoporosis	8.38e-06	8.71e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PSMA2—osteoporosis	8.33e-06	8.65e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PSMA5—osteoporosis	8.33e-06	8.65e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IRS2—osteoporosis	8.32e-06	8.64e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ACP5—osteoporosis	8.26e-06	8.58e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IRS2—osteoporosis	8.25e-06	8.56e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—LEP—osteoporosis	8.14e-06	8.46e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IRS2—osteoporosis	8.14e-06	8.45e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—LEP—osteoporosis	8.07e-06	8.38e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IRS1—osteoporosis	7.97e-06	8.28e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—LEP—osteoporosis	7.97e-06	8.27e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—POMC—osteoporosis	7.96e-06	8.27e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—MTHFR—osteoporosis	7.86e-06	8.17e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.8e-06	8.1e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ESR1—osteoporosis	7.77e-06	8.07e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—POMC—osteoporosis	7.74e-06	8.04e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ESR1—osteoporosis	7.7e-06	8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IRS2—osteoporosis	7.7e-06	8e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ADCY5—osteoporosis	7.7e-06	7.99e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—POMC—osteoporosis	7.68e-06	7.97e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TPI1—osteoporosis	7.68e-06	7.97e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ESR1—osteoporosis	7.61e-06	7.9e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IRS2—osteoporosis	7.58e-06	7.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—LEP—osteoporosis	7.54e-06	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6R—osteoporosis	7.49e-06	7.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SPP1—osteoporosis	7.45e-06	7.73e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—POMC—osteoporosis	7.42e-06	7.71e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—LEP—osteoporosis	7.42e-06	7.7e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IGF1—osteoporosis	7.39e-06	7.67e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IRS1—osteoporosis	7.26e-06	7.54e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO1—osteoporosis	7.23e-06	7.51e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—P4HB—osteoporosis	7.22e-06	7.5e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IRS1—osteoporosis	7.2e-06	7.48e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ESR1—osteoporosis	7.2e-06	7.47e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ADCY5—osteoporosis	7.15e-06	7.43e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PSMA2—osteoporosis	7.12e-06	7.4e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PSMA5—osteoporosis	7.12e-06	7.4e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IRS1—osteoporosis	7.11e-06	7.38e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GAPDH—osteoporosis	7.08e-06	7.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ESR1—osteoporosis	7.08e-06	7.36e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—POMC—osteoporosis	7e-06	7.27e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—POMC—osteoporosis	6.93e-06	7.2e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SPP1—osteoporosis	6.92e-06	7.18e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—RAP1A—osteoporosis	6.9e-06	7.17e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—POMC—osteoporosis	6.84e-06	7.11e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6R—osteoporosis	6.82e-06	7.09e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—osteoporosis	6.81e-06	7.08e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFB1—osteoporosis	6.8e-06	7.06e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6R—osteoporosis	6.76e-06	7.02e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.76e-06	7.02e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IRS2—osteoporosis	6.73e-06	6.99e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF1—osteoporosis	6.73e-06	6.99e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IRS1—osteoporosis	6.72e-06	6.98e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6R—osteoporosis	6.68e-06	6.93e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF1—osteoporosis	6.67e-06	6.92e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IRS1—osteoporosis	6.62e-06	6.87e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—LEP—osteoporosis	6.59e-06	6.84e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF1—osteoporosis	6.58e-06	6.84e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—POMC—osteoporosis	6.47e-06	6.72e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—osteoporosis	6.38e-06	6.63e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—POMC—osteoporosis	6.37e-06	6.62e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6R—osteoporosis	6.32e-06	6.56e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ESR1—osteoporosis	6.29e-06	6.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—POMC—osteoporosis	6.29e-06	6.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IRS2—osteoporosis	6.26e-06	6.5e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF1—osteoporosis	6.23e-06	6.47e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6R—osteoporosis	6.22e-06	6.46e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1—osteoporosis	6.13e-06	6.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—LEP—osteoporosis	6.12e-06	6.36e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IRS1—osteoporosis	5.88e-06	6.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ESR1—osteoporosis	5.84e-06	6.07e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.78e-06	6e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—POMC—osteoporosis	5.66e-06	5.88e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—osteoporosis	5.65e-06	5.87e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO1—osteoporosis	5.58e-06	5.79e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ADCY5—osteoporosis	5.52e-06	5.74e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6R—osteoporosis	5.52e-06	5.73e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX1—osteoporosis	5.5e-06	5.72e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PSMA2—osteoporosis	5.5e-06	5.71e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PSMA5—osteoporosis	5.5e-06	5.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IRS1—osteoporosis	5.46e-06	5.67e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1—osteoporosis	5.44e-06	5.65e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—POMC—osteoporosis	5.26e-06	5.46e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—osteoporosis	5.15e-06	5.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6R—osteoporosis	5.13e-06	5.33e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—osteoporosis	5.12e-06	5.32e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—osteoporosis	5.1e-06	5.3e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTHFR—osteoporosis	5.08e-06	5.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1—osteoporosis	5.06e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—osteoporosis	5.03e-06	5.23e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—osteoporosis	4.76e-06	4.95e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ADCY5—osteoporosis	4.72e-06	4.9e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX1—osteoporosis	4.7e-06	4.89e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—osteoporosis	4.69e-06	4.87e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.46e-06	4.63e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—osteoporosis	4.44e-06	4.61e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFB1—osteoporosis	4.43e-06	4.6e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTHFR—osteoporosis	4.34e-06	4.51e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—osteoporosis	4.16e-06	4.32e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—POMC—osteoporosis	4.06e-06	4.22e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—osteoporosis	4.04e-06	4.2e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFB1—osteoporosis	4.03e-06	4.19e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—osteoporosis	4.01e-06	4.16e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFB1—osteoporosis	4e-06	4.15e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—osteoporosis	3.96e-06	4.11e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFB1—osteoporosis	3.95e-06	4.1e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—osteoporosis	3.87e-06	4.02e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—osteoporosis	3.74e-06	3.89e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFB1—osteoporosis	3.73e-06	3.88e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—osteoporosis	3.68e-06	3.83e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFB1—osteoporosis	3.67e-06	3.82e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ADCY5—osteoporosis	3.64e-06	3.78e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX1—osteoporosis	3.63e-06	3.77e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—POMC—osteoporosis	3.47e-06	3.61e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTHFR—osteoporosis	3.35e-06	3.48e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—osteoporosis	3.34e-06	3.47e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—osteoporosis	3.27e-06	3.4e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFB1—osteoporosis	3.26e-06	3.39e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—osteoporosis	3.04e-06	3.16e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—osteoporosis	3.04e-06	3.16e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFB1—osteoporosis	3.03e-06	3.15e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—osteoporosis	3.01e-06	3.13e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—osteoporosis	2.97e-06	3.09e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—osteoporosis	2.81e-06	2.92e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—osteoporosis	2.77e-06	2.88e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—POMC—osteoporosis	2.68e-06	2.78e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—osteoporosis	2.46e-06	2.55e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—osteoporosis	2.29e-06	2.37e-05	CbGpPWpGaD
